/
/
/

Akums Drugs & Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)784.40
Volume (₹)3.39 L
High (₹)785.00
Upper Circuit858.60
Low (₹)748.35
Lower Circuit702.50
Prev Close780.55
52W High (₹)796.55
Price765.75
52W Low (₹)409.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)12299.60 Cr
Div. Yield (%)0.38
PE Ratio42.16
Debt to Equity0.02
Price to Book2.15
Book Value216.41
EPS (TTM)18.53
Face Value2.00
ROE (%)8.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
AKUMSNSE
LTP
1W Low
1W High
Market cap (₹)
1899-85.8 (-4.32%)
1895
1984.80
4,56,833Cr
9100-367 (-3.88%)
9087
9467
2,45,426Cr
4857-209 (-4.13%)
4823
5066
1,87,320Cr
1120-41.3 (-3.56%)
1120
1187
1,13,217Cr
1385-24.2 (-1.72%)
1375.50
1426.10
1,12,212Cr
1840-75 (-3.92%)
1811.70
1949
1,01,155Cr
2110-78.4 (-3.58%)
2100.60
2192
97,626Cr
2327.9-91.3 (-3.77%)
2317
2419.20
96,859Cr
1151-3.4 (-0.29%)
1151
1179.90
96,406Cr
1653.1-63.9 (-3.72%)
1622.60
1717
93,614Cr
765.75-10.95 (-1.41%)
748.35
796.55
12,300Cr

Key Highlights of Akums Drugs & Pharmaceuticals Ltd Balance Sheet

Akums Drugs & Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹30.62Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹30.62Cr, and the reserves and surplus of the company is ₹2396.95Cr.

The company has its non-current liabilities with total liabilities of ₹2812.48Cr as of 2026-03-31.

The current liabilities are ₹304Cr as of 2026-03-31. At the same time, current assets are ₹1323.5Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹366.02Cr and tangible assets of ₹406.93Cr, provided in the Akums Drugs & Pharmaceuticals Ltd financial statements.